Dissociation kinetics of G proteins from G protein–coupled receptors and effects of allosteric modulation

J Jinan Wang A Anh T. N. Nguyen (Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University) V Victor A. Adediwura (Department of Pharmacology and Computational Medicine Program, University of North Carolina) C Cam Sinh Lu (Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University) S Samantha M. McNeill (Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University) M Manuela Jörg (Medicinal Chemistry Theme, Monash Institute of Pharmaceutical Sciences) P Peter J. Scammells (Medicinal Chemistry Theme, Monash Institute of Pharmaceutical Sciences, Monash University) A Arthur Christopoulos (Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University) L Lauren T. May (Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University) Y Yinglong Miao

Abstract

G protein–coupled receptors (GPCRs), the largest superfamily of human membrane proteins with >800 members, are primary targets for ~1/3 of all marketed drugs. Recent fluorescence experiments underscored the pivotal role of GPCR–G protein complex lifetime in their coupling efficiency and selectivity. However, these experiments are often expensive, time-consuming, and limited to a small number of GPCR–G protein systems. On the other hand, it is challenging to simulate GPCR–G protein dissociation using molecular dynamics (MD) methods. Here, we have employed Protein–Protein Interaction Gaussian accelerated MD (PPI-GaMD) simulations and experiments to probe the kinetics and pathways of G protein dissociation from GPCRs. For five systems with published experimental kinetic data, PPI-GaMD simulations successfully captured G protein dissociation from the GPCRs, including the adrenergic, adenosine, and muscarinic receptors. The simulations allowed identification of two distinct dissociation pathways and calculation of the G protein dissociation rates, which were in good agreement with experimental data. Additionally, we simulated the effect of positive allosteric modulators (PAMs) of the adenosine A 1 receptor (A 1 R) in Gi protein dissociation and supported simulation findings with bioluminescence resonance energy transfer biosensor experiments evaluating G βγ kinetics following A 1 R activation. A 1 R PAMs were found to strengthen the agonist–receptor and receptor–G protein interactions and significantly reduce dissociation rates of the Gi protein. In summary, complementary PPI-GaMD simulations and kinetic assays have enabled detailed characterization of the kinetics and pathways of G protein dissociation, a critical event in the GPCR signaling cascade, and the effects of GPCR allosteric modulators.

Article Details

Volume / Issue Vol. 122, Issue 46
Published November 18, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

J

Jinan Wang

A

Anh T. N. Nguyen

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University

V

Victor A. Adediwura

Department of Pharmacology and Computational Medicine Program, University of North Carolina

C

Cam Sinh Lu

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University

S

Samantha M. McNeill

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University

M

Manuela Jörg

Medicinal Chemistry Theme, Monash Institute of Pharmaceutical Sciences

P

Peter J. Scammells

Medicinal Chemistry Theme, Monash Institute of Pharmaceutical Sciences, Monash University

A

Arthur Christopoulos

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University

L

Lauren T. May

Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University

Y

Yinglong Miao